Judi Health
Category: AI in Healthcare
Capital Rx (rebranded as Judi Health) is a health technology company offering a unified platform for pharmacy and medical claims processing to provide transparent and affordable health benefits. Judi Health was founded in 2017. The company is led by Anthony J. Loiacono. Based in New York, USA. Team size: 501-1000. Total funding raised: $673.5M. Latest round: Series F, $252.0M, 2025-09, led by Wellington Management and General Catalyst. Key investors include Prime Therapeutics, Transformation Capital, B Capital, General Catalyst, Banner Health.
- Founded
- 2017
- Headquarters
- New York, USA
- Team size
- 501-1000
- Total funding
- $673.5M
Value proposition
To reduce healthcare costs and improve patient outcomes through a transparent pricing model and a modern, unified technology platform for managing pharmacy and medical benefits.
Products and solutions
Judi Health Platform: A cloud-native enterprise health platform for unified pharmacy and medical claims processing., Pharmacy Benefit Management (PBM): Full-service PBM for employers and other plan sponsors., Pharmacy Benefit Administration (PBA): PBA services for health plans and TPAs.
Unique value
Capital Rx's primary unique factor is its Judi Health Platform, which is the industry's first to unify pharmacy and medical claims processing on a single, cloud-native platform. This contrasts with the traditionally siloed and outdated systems used in the healthcare industry. They also differentiate themselves with a transparent pricing model for prescription drugs.
Target customer
Employers, health plans, third-party administrators (TPAs), unions, municipalities, and government entities.
Industries served
Healthcare, Insurance, Government
Technology advantage
The core technological advantage is the JUDI Health Platform, an API-first, cloud-native system that offers flexibility, scalability, and efficiency. This modern infrastructure allows for seamless integration and a single source of truth for all benefits data, enabling better cost management and member care. Their business advantage lies in their transparent model, which aligns their interests with those of their clients.
How they differentiate
Capital Rx differentiates itself with its technology-driven approach, centered around its proprietary platform, JUDI®. This platform aims to bring transparency and efficiency to the traditionally opaque pharmacy benefit management (PBM) industry. The company's key differentiator is its transparent pricing model, which eliminates spread pricing and rebates that are common among traditional PBMs. Instead, Capital Rx uses a fee-based model, which they claim aligns their incentives with those of their clients, leading to lower drug costs.
Main competitors
CVS Caremark, Express Scripts, OptumRx
Key partnerships
Prime Therapeutics: A strategic alliance providing Prime Therapeutics with exclusive access to Capital Rx's technology platform to serve its more than 50 million members., ELMCRx Solutions: A partnership to expand innovative PBM solutions., New York City FC: A sleeve partnership for brand visibility.
Notable customers
While specific client names are often kept confidential, Capital Rx serves a diverse range of customers including employers, unions, health plans, and government entities. They have published case studies with organizations like a large Texas-based health plan and a multi-state manufacturing company, demonstrating significant cost savings.
Major milestones
Achieved unicorn status with a valuation of over $1 billion, which later grew to a reported $3.25 billion., Successfully launched and scaled its proprietary enterprise health platform, JUDI®., Secured a major funding round of $400 million in October 2025 to accelerate its AI-powered health benefits platform., Announced a rebranding to 'Judi Health' to reflect the company's expansion beyond pharmacy benefits into broader healthcare services., Recognized on the Deloitte Technology Fast 500 list as one of the fastest-growing companies in North America.
Growth metrics
As of early 2025, Capital Rx was reported to have reached $3.5 billion in revenue, showcasing significant growth in the competitive PBM market.
Market positioning
Capital Rx is positioned as a high-growth, technology-focused disruptor in the PBM market. It has achieved 'unicorn' status, indicating a valuation of over $1 billion, and is considered one of the fastest-growing companies in its sector. The company targets employers, health plans, and government entities that are seeking more transparency and cost-effectiveness in their pharmacy benefits. By leveraging its modern technology platform, Capital Rx aims to capture market share from the larger, more established PBMs.
Geographic focus
United States
Patents and IP
Information regarding specific patents or IP is not publicly available.
About Anthony J. Loiacono
Over 20 years of experience in pharmacy benefits, finance, and software development. Co-founder of Capital Rx (now Judi Health).
Official website: https://www.judi.health